Research Directory

Why the time has come for MidPharmas

Read more

Alkermes pioneers trial design in depression

Read more

The EU Clinical Trials Regulation: Legislators see light at the end of the tunnel

Read more

Oncology Development Review - 2013: Competition for new cancer treatments intensifies

Read more

Commentary: The outlook for biotech seems rosy - for now

Read more

Outlook brightens for regenerative medicine

Read more

Targeting new medicines at Roche

Read more

MorphoSys Innovation Capital: A venture fund with appetite for platforms

Read more

Banner year for biotechs

Read more

What entrepreneurs should know about China

Read more